Last update 15 Feb 2025

Hemay181

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HEMAY 181, HEMAY-181
Target-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Advanced Malignant Solid NeoplasmBreast CancerColorectal Cancer+ [5]
Inactive Indication-
Originator Organization
Ganzhou Hemei Pharmaceutical Co Ltd
Active Organization
Ganzhou Hemei Pharmaceutical Co Ltd
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Hemay181
NCT05749432
/ RecruitingPhase 1
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Antitumor Efficacy of Hemay181 in Patients With Advanced Solid Tumors
CTR20230365
/ RecruitingPhase 1
评价 Hemay181 在晚期实体瘤患者中安全性、耐受性、药代动力学特征和初步抗肿瘤疗效的Ⅰ期临床研究
[Translation] A phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary anti-tumor efficacy of Hemay181 in patients with advanced solid tumors
100 Clinical Results associated with Hemay181
Login to view more data
100 Translational Medicine associated with Hemay181
Login to view more data
100 Patents (Medical) associated with Hemay181
Login to view more data
100 Deals associated with Hemay181
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Breast CancerPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Colorectal CancerPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Esophageal CarcinomaPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Liver CancerPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Non-Small Cell Lung CancerPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Pancreatic CancerPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Stomach CancerPhase 1
CN
Ganzhou Hemei Pharmaceutical Co Ltd
08 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free